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microdissected and assayed Tor NPY content using a 
, s p e c i f i c  radioimunoassay. 
,Food and water in takes  were s i g n i f i c a n t l y  increased by 
21% (p<O.Ol )  and 38% ( p < O . O O t )  respect ively i n  t h e  MA- 
t rea ted  group. NPY l eve ls  were ra i sed  i n  t h e  MA-treated 
'group, i n  t h e  arcuate  nucleus ( b y  143%. pC0.05), the  
,medial preopt ic  a rea  (93%, p<0.05), t h e  dorsomedial 
nucleus (92%, ~ ( 0 . 0 5 ) .  t h e  l a t e r a l  hypothalamic area 
(122%. pC0.05) and i n  t h e  ventromedial nucleus (130%, 
pCO.05). 
The  arcuate  nucleus is t h e  main hypothalamic s i t e  of NPY 
s y n t h e s i s .  Increased levels i n  t h i s  nucleus and in  t h e  
other  regions therefore sugges t  increased a c t i v i t y  of t h e  
NPYergic s y s t e m .  A l l  these regions are s e n s i t i v e  t o  
N P Y ' s  appet i te-s t imulat ing a c t i o n ,  sugges t ing  t h a t  
increased NPY re lease  may mediate t h e  a p p e t i t e -  
s t i m u l a t i n g  e f fec t  of MA. 
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Methysergide (Meth) is a non selective 5-HT antrtgonist which 
stimulates feeding in rats. 5-HT has been suggested to induce satiety. 
Neuropeptide Y (NPY) is a 36 amino-acid peptide sbucturally related 
to pancreatic polypeptide. and one of the most abundant newpeptide 
in the brain. 
5-HT fibres project to the hypothalamus particularly the 
paravenmcular(PVN) and arcuatc (ARC) nuclei, sites of NPY action 
and synthesis respectively. 
This study set out to examine the effect of acute and chronic 
adminisnation of methysergide on hypothalamic NPY. 
Male Wism rats were used. In the acute experiment, rats were 
injected with either saline (0.9% n=8) or methysergide(l0mgkg n=8) 
and killed after four hours. 
In the chronic experiment, rats were implanted with mini-osmotic 
pumps filled with either saline (n=8) or methysergide (lOmgkg/day 
n=8). Rats were killed after seven days. 
Food infake was greater in  the methysergide treated rats after four 
hours compared with the saline treated rats @<0.01). 
NPY levels were significantly increased in the PVN and ARC in the 
methysergide treated rats (PVN 61 rf 3.2 vs 47 rf 3 fmoUug protein 
p<O.OI. ARC 49 rf 4.2 vs 27 * 3.2 pcO.01) 
In the chronically mated rats food intake was raised by 13% over 
seven days (pcO.01). 
Again NPY levels were significantly increased in  the methysergide 
treated rats (PVN 66 2 6.2 vs 47 2 3.1 fmoVug protein p=O.Ol. ARC 
38.5 2 3 vs 27.4 L 3.2 p=0.02). 
These results suggest that methysergide induced feeding is associated 
with changesin NPYergic activity in  critical hypothalamic areas. 
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Nicotine administption has an inverse relationship with body 
weight. 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION 
Cigarette smoking reduces food intake, and a carbohydrate- 
specific craving often develops after cessation of smoking. 
The effect of nicotine administration on hypothalamic 
Neuropeptide Y (NPY) levels, an endogenous potent appetite 
stimulant, particularly for carbohydrate was assessed in a 12 
day study in rats. 
Three groups of rats were implanted (s.c.) with mini-osmotic 
pumps, one group containing nicotine dihydrochloride (12mgn(g 
/day n=8) and two groups containing saline (0.9% rk8.8)). 
The nicotine treated rats and one of the saline groups were 
allowed to free-feed for twelve days. 
The second saline treated group were pair-fed to the level of 
food intake of the nicotine treated rats. 
Food intake in the nicotine treated rats was reduced by 11% 
over the twelve days @=0.02). and body weight gain reduced by 
10% over the twelve days (p<O.O2). 
NPY levels were significantly lower in the nicotine treated and 
pair-fed rats compared with the control rats (PVN 62 2 6.5 vs 
91.2 2 6.3 fmol/ug protein pc0.01, ARC 33 L 4.9 vs 49 2 4.0 
fmol/ug protein p=O.Ol. pair-fed PVN 74 2 3.7 vs 91.2 2 6.3 
These results suggest that the hypophagia associated with 
nicotine treatment may be a result of reduced hypothalamic 
NPYergic activity. 
p=0.03) 
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Neuropeptide Y (NPY) is a potent centrally acting appetite-stimulating 
peptide implicated in the regulation of energy balance. It induces 
hyperphagia and obesity when injected into the rat hypothalamus. 
Hypothalamic NPY and NPY mRNA levels are increased in spontaneously 
obese rats. suggesting that it may be involved in causing obesity in rodents. 
It is not known whether NPY has a role in the pathogenesis of obesity in 
man. NPY is found in human cerebrospinal lluid (CSF) and we have 
therefore compared CSF NPY levels in normal obese and nowobese 
individuals. to determine whether NPY concentrations mght be increased in 
We studied 25 clinically normal subjects (age 67 f 5 years, male 11, 
lemale 14) undergoing spinal anaesthesia. None had any significant illness. 
Samples of 1 ml were freeze-dried and reconstituted to 100 ul. and 35.~1 
aliquots were assayed lor NPY using an in-house RIA. CSF NPY levels 
were no1 correlated with body mass index (BMI) (r.0.088. p-0.673) and 
there were no differences in NPY concentrations between groups 01 subjects 
stratified lor BMI: BMI <22 (n-7). 695 * 77 (SEM) hnollml: BMI 22-25 (n-7). 
701 82 lmollml; BMI >25 (n-11). 702 55 ImoVml (differences between all 
groups, pA.1). 
CSF NPY levels are therelore not increased in human obesity. NPY 
is found in many brain regions cutside the hypothalamic appetiteregulating 
nuclei, which could contribute lo CSF levels. This negative observation does 
not therefore exclude a role of the peptde. acting specifcally in the 
hypothalamus. in contributing to human obesity. 
obesity. 
161 ACUTE COLD EXPOSURE INCREASES NEUROPEPTIDE Y 
LEVELS I N  SPECIFIC REGIONS OFTHE RAT HYPOTHALAMUS 
WHICH REGULATE ENERGY BALANCE 
H D McCARTHY, AP IULPATRICK, P TRAYHURN' and G 
WILLIAMS 
University Department of Medicine, Liverpool L69 3BX. *Division of 
Biochemistry. Rowett Research Institute, Aberdeen AB2 9SB 
Neuropeptide Y (NPY) is implicated in the regulation of energy 
balance and reduces energy expenditure, by inhibiting activation of 
